EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieValidierungsstudie

Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial

Jeffrey J Siracuse, Alik Farber, Matthew T Menard, Kenneth Rosenfield, Michael S Conte, Andres Schanzer, Gheorghe Doros, Raghu Motaganahalli, Igor J Laskowski, Neal R Barshes, Elizabeth A Genovese, Michael B Strong und 1 weitere

Journal of Vascular Surgery · 2025-03 · 81 (3) · 720-729.e1

DOI: 10.1016/j.jvs.2024.11.027 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2025-03. Verfasst von Jeffrey J Siracuse und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Ce…. Hauptthemen laut MEDLINE: Ischemia, Endovascular Procedures, Peripheral Arterial Disease, Wound Infection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: NHLBI NIH HHS, Novo Nordisk Fonden, National Heart Lung and Blood Institute Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Wound, Ischemia, and foot Infection (WIfI) staging was established to provide objective classification in patients with chronic limb-threatening ischemia (CLTI) and to predict 1-year major amputation risk. Our goal was to validate WIfI staging using data from the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial. METHODS: Data from the BEST-CLI Trial, a prospective randomized trial comparing surgical revascularization (OPEN) and endovascular revascularization (ENDO), were used to assess the association of WIfI stage on long-term outcomes in an intention-to-treat analysis. Patients were prospectively allocated to two cohorts, which included patients with and without adequate single-segment greater saphenous vein, respectively. The primary outcome of this analysis was major amputation. RESULTS: There were 1568 patients analyzed, representing 86% of the entire trial population; of these 35.5%, 29.6%, and 34.9% were categorized as WIfI stage 4, WIfI stage 3, and WIfI stage 1/2, respectively. There were 1223 patients (606 OPEN, 617 ENDO) and 345 patients (OPEN 172, ENDO 173) in cohorts 1 and 2, respectively. On unadjusted Kaplan-Meier analysis, WIfI clinical stages 4 and 3, compared with WIfI stage 1/2, were associated with higher rates of major amputation (21.4%, 16.2% vs 10.7%), death (33.5%, 35.7% vs 24.6%), amputation/death (44.9%, 44.5% vs 31.3%), major adverse limb events (MALEs)/death (34.4%, 33.9% vs 29.5%), and reintervention/amputation/death (69.9% vs 69% vs 60.4%) (P < .05 for all) at 3 years. On risk-adjusted analysis, compared with WIfI stage 1/2, major amputation was associated with WIfI stage 4 (hazard ratio [HR], 2.06; 95% confidence interval [CI], 1.44-2.96; P < .001) and WIfI stage 3 (HR, 1.62; 95% CI, 1.1-2.37; P = .013) stages. Death was associated with WIfI stage 4 (HR, 1.3; 95% CI, 1.03-1.63; P = .027) and WIfI stage 3 (HR, 1.42; 95% CI, 1.13-1.79; P = .003). MALE/death was associated with WIfI stage 4 (HR, 1.29; 95% CI, 1.02-1.63; P = .036. Reintervention amputation/death was associated with WIfI stage 4 (HR, 1.28; 95% CI, 1.09-1.50; P = .03) and WIfI stage 3 (HR, 1.22, 99% CI 1.03-1.43) ; P = .018). When examining OPEN vs ENDO revascularization by each WIfI stage, OPEN intervention was favored in cohort 1 for MALE/death for each stage. CONCLUSIONS: In BEST-CLI, WIfI stage was strongly associated with major amputations, death, and MALEs/death after revascularization for CLTI. Cohort 1 patients, with an adequate preoperative single segment greater saphenous vein, had lower MALE/death with OPEN intervention across all WIfI stages. This validation of WIfI score in a prospective multicenter trial reinforces its importance in shared-decision making, informed consent, and prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IschemiaEndovascular ProceduresPeripheral Arterial DiseaseWound InfectionVascular Surgical ProceduresWound HealingChronic Limb-Threatening IschemiaHumansAmputation, SurgicalMaleFemaleAgedLimb SalvageTreatment OutcomeTime FactorsRisk FactorsMiddle AgedProspective StudiesRisk AssessmentSeverity of Illness IndexIntention to Treat AnalysisKaplan-Meier EstimatePredictive Value of TestsChronic DiseaseSaphenous Vein

Stichwörter der Autor:innen

InfectionPeripheral arterial diseaseRevascularizationWound

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Department of Surgery, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, MA. Electronic address: Jeffrey.Siracuse@bmc.org.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, MA.
  • Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA.
  • Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA.
  • Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA.
  • Division of Vascular and Endovascular Surgery, University of Massachusetts, Worcester, MA.

Förderung

  • NHLBI NIH HHS
  • Novo Nordisk Fonden
  • National Heart Lung and Blood Institute Division of Intramural Research

Zitieren

APA

Siracuse, J. J., Farber, A., Menard, M. T., Rosenfield, K., Conte, M. S., Schanzer, A., Doros, G., Motaganahalli, R., Laskowski, I. J., Barshes, N. R., Genovese, E. A., Strong, M. B., & Mills, J. L. (2025). Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial. Journal of Vascular Surgery, 81(3), 720-729.e1. https://doi.org/10.1016/j.jvs.2024.11.027

Vancouver

Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, et al. Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial. Journal of Vascular Surgery. 2025;81(3):720-729.e1. doi:10.1016/j.jvs.2024.11.027

BibTeX
@article{Siracuse2025,
  author = {Siracuse, Jeffrey J and Farber, Alik and Menard, Matthew T and Rosenfield, Kenneth and Conte, Michael S and Schanzer, Andres and Doros, Gheorghe and Motaganahalli, Raghu and Laskowski, Igor J and Barshes, Neal R and Genovese, Elizabeth A and Strong, Michael B and Mills, Joseph L},
  title = {Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  volume = {81},
  number = {3},
  pages = {720--729.e1},
  doi = {10.1016/j.jvs.2024.11.027}
}
Kostenlos starten →